Your session is about to expire
← Back to Search
Device
tDCS for Depression (MoodStim Trial)
N/A
Waitlist Available
Led By Alvaro Pascual-Leone, Dr.
Research Sponsored by Hebrew SeniorLife
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Summary
The investigators propose a study of telehealth supervised, caregiver-delivered, home-based transcranial direct current stimulation (tDCS) for antidepressant treatment of patients with an acute depressive episode.
Eligible Conditions
- Depression
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mental Depression
Number of Treatment-Emergent Adverse Events [Safety and Tolerability] and Missed Sessions
Secondary study objectives
Beck Depression Inventory (BDI)
Digit Span Backward
Digit Span Forward
+4 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: tDCS MDDExperimental Treatment1 Intervention
A group of 5 participants with major depressive disorder (MDD).
tDCS, as a relatively simple and portable technology, is particularly well suited for remotely-supervised, home-based treatment, which would facilitate longer periods of treatment as well as offer a suitable therapeutic option at the present time as the investigators aim to deal with the COVID-19 pandemic.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
tDCS
2017
Completed Phase 2
~640
Find a Location
Who is running the clinical trial?
Hebrew SeniorLifeLead Sponsor
46 Previous Clinical Trials
270,744 Total Patients Enrolled
4 Trials studying Depression
79 Patients Enrolled for Depression
Alvaro Pascual-Leone, Dr.3.97 ReviewsPrincipal Investigator - Hinda and Arthur Marcus Institute for Aging Research
Hebrew SeniorLife
2 Previous Clinical Trials
54 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger